Mason has answered your question; I'm just repeating in different words.
FTO levels don't change.
What changes is the activity of that FTO as measured by changes in methylation of m6A.
This m6A methylation effect can and will be measured during the bisantrene lead-in dose before the other drug starts to be administered.
- Forums
- ASX - By Stock
- RAC
- Speculative M&A Transaction Analysis
Speculative M&A Transaction Analysis, page-724
-
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.68 |
Change
0.050(3.08%) |
Mkt cap ! $285.4M |
Open | High | Low | Value | Volume |
$1.65 | $1.75 | $1.64 | $210.4K | 125.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 1.645 |
1 | 12000 | 1.630 |
2 | 4461 | 1.625 |
1 | 5000 | 1.620 |
2 | 10500 | 1.605 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 595 | 1 |
1.695 | 7597 | 2 |
1.700 | 11000 | 1 |
1.730 | 2399 | 1 |
1.750 | 952 | 2 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |